![Hero](https://velsera.com/hubfs/Hero.png)
![Hero](https://velsera.com/hubfs/Hero.png)
Whole genome sequencing for metastatic mutational burden in extraskeletal myxoid chondrosarcoma
Multi-omics Pathways Workflow (MOPAW): An Automated Multi-omics Workflow on the Cancer Genomics Cloud.
Building a collaborative cloud platform to accelerate heart, lung, blood, and sleep research.
Addressing barriers in FAIR data practices for biomedical data.
![Velsera_blog](https://velsera.com/hubfs/Blog%20post/Velsera_blog.png)
![Velsera_blog](https://velsera.com/hubfs/Blog%20post/Velsera_blog.png)
Unravelling Cellular Complexity: Exploring 3D Genome Structure and DNA Methylation with the snM3C Pipeline
![Velsera_blog](https://velsera.com/hubfs/Blog%20post/Velsera_blog.png)
Four Years, Five Stages: What the FDA's Final Rule on LDTs Means for Complex Molecular Diagnostic Testing
Document library.
The Seven Bridges Platform
Accelerating your drug discovery process with Velsera's enterprise-grade bioinformatics ecosystem.
GRAF
A better approach to NGS data analysis: building a pan-genome graph containing population genetics.
Clinical Genomics Workspace
All-in-one analysis and reporting tool for clinical NGS data, enhancing the quality and efficiency of patient care delivery.
Webinars and
videos.
![GRAF Webinar on demand](https://velsera.com/hubfs/GRAF%20Webinar%20on%20demand.png)
Accelerating Drug Discovery: How GRAF Pangenomes Enable Enhanced Insights From Sequencing Data.
Uncover solutions to the pressing challenges in Next-Generation Sequencing (NGS) data analysis with Velsera. Join our upcoming webinar to address a pivotal pain point in genomics: reference bias. Learn how Velsera's GRAF solution tackles reference bias and seamlessly integrates with existing pipelines, lowering computational costs and elevating your NGS analysis efficiency.
![Group 8429](https://velsera.com/hubfs/Group%208429.png)
State of the Union: NGS Reimbursement.
In the recorded session, you will learn about how the new 2024 CPT codes may impact your organization's reimbursement rates, current trends for NGS reimbursement, the Medicare Gapfill process and more!
![Group 8430](https://velsera.com/hubfs/Group%208430.png)
Unleashing the Power of Neoantigens: Bridging Discovery, Cutting-Edge Scientific Breakthroughs and Medical Innovation.
Julie Gil, Senior Scientific Partner at Velsera, explores the frontier of bioinformatics and immunology. In this illuminating talk, Julie explores the groundbreaking world of neoantigens, revealing how they hold the key to revolutionizing the fields of immunotherapy and personalized medicine.
![GRAF Webinar on demand](https://velsera.com/hubfs/GRAF%20Webinar%20on%20demand.png)
Accelerating Drug Discovery: How GRAF Pangenomes Enable Enhanced Insights From Sequencing Data.
Uncover solutions to the pressing challenges in Next-Generation Sequencing (NGS) data analysis with Velsera. Join our upcoming webinar to address a pivotal pain point in genomics: reference bias. Learn how Velsera's GRAF solution tackles reference bias and seamlessly integrates with existing pipelines, lowering computational costs and elevating your NGS analysis efficiency.
![Group 8429](https://velsera.com/hubfs/Group%208429.png)
State of the Union: NGS Reimbursement.
In the recorded session, you will learn about how the new 2024 CPT codes may impact your organization's reimbursement rates, current trends for NGS reimbursement, the Medicare Gapfill process and more!
![Group 8430](https://velsera.com/hubfs/Group%208430.png)
Unleashing the Power of Neoantigens: Bridging Discovery, Cutting-Edge Scientific Breakthroughs and Medical Innovation.
Julie Gil, Senior Scientific Partner at Velsera, explores the frontier of bioinformatics and immunology. In this illuminating talk, Julie explores the groundbreaking world of neoantigens, revealing how they hold the key to revolutionizing the fields of immunotherapy and personalized medicine.